COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.

Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, Joshi M, Kuwana M, Saha S, Pande AR, Caballero-Uribe CV, Velikova T, Parodis I, Knitza J, Kadam E, Tan AL, Shinjo SK, Boro H, COVAD Study Group, Aggarwal R, Agarwal V, Chatterjee T, Gupta L

Open source

DOI: 10.1007/s00296-023-05496-y
Published: 2024 Jan
Container: Rheumatology international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00296-023-05496-y,
  title = {COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.},
  author = {Panchawagh S and Ravichandran N and Barman B and Nune A and Javaid M and Gracia-Ramos AE and Day J and Joshi M and Kuwana M and Saha S and Pande AR and Caballero-Uribe CV and Velikova T and Parodis I and Knitza J and Kadam E and Tan AL and Shinjo SK and Boro H and COVAD Study Group and Aggarwal R and Agarwal V and Chatterjee T and Gupta L},
  year = {2024},
  journal = {Rheumatology international},
  doi = {10.1007/s00296-023-05496-y},
  url = {https://doi.org/10.1007/s00296-023-05496-y}
}

RIS

TY  - JOUR
TI  - COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
AU  - Panchawagh S
AU  - Ravichandran N
AU  - Barman B
AU  - Nune A
AU  - Javaid M
AU  - Gracia-Ramos AE
AU  - Day J
AU  - Joshi M
AU  - Kuwana M
AU  - Saha S
AU  - Pande AR
AU  - Caballero-Uribe CV
AU  - Velikova T
AU  - Parodis I
AU  - Knitza J
AU  - Kadam E
AU  - Tan AL
AU  - Shinjo SK
AU  - Boro H
AU  - COVAD Study Group
AU  - Aggarwal R
AU  - Agarwal V
AU  - Chatterjee T
AU  - Gupta L
PY  - 2024
JO  - Rheumatology international
DO  - 10.1007/s00296-023-05496-y
UR  - https://doi.org/10.1007/s00296-023-05496-y
ER  -

APA

S, P., N, R., B, B., A, N., M, J., AE, G., J, D., M, J., M, K., S, S., AR, P., CV, C., T, V., I, P., J, K., E, K., AL, T., SK, S., H, B., Group, C. S., R, A., V, A., T, C., & L, G. (2024). COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.. Rheumatology international. https://doi.org/10.1007/s00296-023-05496-y

Source records

pubmed · retrieved 2026-09-27T00:20:36.469Z